<DOC>
	<DOCNO>NCT02268604</DOCNO>
	<brief_summary>Study ass safety , pharmacodynamics pharmacokinetics BIIB 722 CL</brief_summary>
	<brief_title>Safety , Pharmacodynamics , Pharmacokinetics After Multiple Different Oral Doses BIIB 722 CL Tablets Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male 18 55 year age Broca index &gt; = 20 % &lt; = +20 % Written inform consent accord Good Clinical Practice ( GCP ) local legislation Any finding medical examination ( include blood pressure , pulse rate ECG ) deviate normal clinical relevance History current gastrointestinal hepatic , renal , respiratory , cardiovascular , metabolic , immunologic , hormonal disorder History orthostatic hypotension , faint spell blackouts Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 hour ) within 1 month prior administration Use drug , might influence result trial within 10 day prior administration trial Participation another trial investigational drug within 2 month prior administration trial Smoker ( &gt; 10 cigarette 3 cigar 3 pipes/day ) inability refrain smoke study day Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation within 1 month prior administration trial Excessive physical activity within 5 day prior administration trial Any laboratory value outside clinically accept reference range</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>